A detailed history of Laurion Capital Management LP transactions in Zoetis Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 148,078 shares of ZTS stock, worth $27.1 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
148,078
Previous 50,000 196.16%
Holding current value
$27.1 Million
Previous $8.46 Million 203.43%
% of portfolio
0.31%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $21.6 Million - $26.5 Million
148,078 New
148,078 $25.7 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $183,732 - $235,706
1,178 New
1,178 $202,000
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $1.93 Million - $2.14 Million
-12,300 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $1.69 Million - $2.03 Million
12,300 New
12,300 $2.03 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $11.7 Million - $14.8 Million
-104,121 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$92.66 - $144.94 $9.65 Million - $15.1 Million
104,121 New
104,121 $12.3 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $420,243 - $481,698
-3,615 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $406,940 - $464,274
3,615 New
3,615 $450,000
Q1 2019

May 08, 2019

SELL
$81.56 - $100.67 $5.05 Million - $6.23 Million
-61,857 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$79.28 - $95.27 $4.42 Million - $5.32 Million
55,803 Added 921.75%
61,857 $5.29 Million
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $32,899 - $36,732
394 Added 6.96%
6,054 $554,000
Q2 2018

Aug 13, 2018

SELL
$79.9 - $89.2 $174,901 - $195,258
-2,189 Reduced 27.89%
5,660 $483,000
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $561,281 - $664,731
7,849 New
7,849 $655,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.